- Research works
- 48 ▲ 64% vs 2013–17
- Citations
- 898 18.5 per fractional work
- Top-10% rate
- 11.6% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Consorzio per Valutazioni Biologiche e Farmacologiche is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 8.0×. Every wedge is a field page.
- Nursing 8.0×
- Immunology and Microbiology 7.8×
- Medicine 2.7×
- Chemistry 2.2×
- Health Professions 2.2×
- Decision Sciences 2.0×
- Mathematics 1.7×
- Agricultural and Biological Sciences 1.4×
- Arts and Humanities 1.4×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Psychology 0.5×
- Environmental Science 0.5×
- Neuroscience 0.5×
- Biochemistry, Genetics and Molecular Biology 0.5×
- Economics, Econometrics and Finance 0.3×
- Social Sciences 0.2×
- Engineering 0.1×
- Computer Science 0.1×
Who are the top researchers at Consorzio per Valutazioni Biologiche e Farmacologiche?
Ranked on the composite score, Adriana Ceci lead among researchers whose main affiliation is Consorzio per Valutazioni Biologiche e Farmacologiche.
- 1 Adriana Ceci Italy · #531,555 worldwide 27 citations · 24 works
Which keywords describe research at Consorzio per Valutazioni Biologiche e Farmacologiche?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Drug Development, Adverse Drug Reactions, Off-Label Drug Use, Pediatric Pharmacokinetics, Primary Care, Oxidative Stress and Social Determinants.
- Deep Learning
- Metabolism
- Chronic Pain
- Spermatogonial Stem Cells
- Animal Welfare
- Cost-effectiveness Analysis
- Generic Drugs
- Pharmaceutical Industry
- Innovation
- Pediatrics
- Public Health
- Inflammation
- Oxidative Stress
- Off-Label Drug Use
- Drug Development
- Clinical Trials
- Adverse Drug Reactions
- Pediatric Pharmacokinetics
- Epidemiology
- Primary Care
- Community Health
- Social Determinants
- Quality of Life
- Drug Development Costs
- Economic Evaluation
- Health Utility Measures
- Sperm DNA Fragmentation
- Neurodegeneration
- Classification
- Treatment
- Literature
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Clinical Trials7▲ 24×8 topics
- Drug Development6▲ 84×2 topics
- Adverse Drug Reactions6▲ 174×2 topics
- Off-Label Drug Use6▲ 302×1 topic
- Pediatric Pharmacokinetics6▲ 302×1 topic
- Oxidative Stress4▲ 4.1×13 topics
- Epidemiology3▲ 1.55×18 topics
- Inflammation3▲ 2.5×20 topics
- Primary Care3▲ 14×2 topics
- Public Health3▲ 4.1×2 topics
- Community Health3▲ 38×1 topic
- Pediatrics3▲ 125×1 topic
- Social Determinants3▲ 29×2 topics
- Innovation2▲ 5.4×4 topics
- Quality of Life2▲ 3.7×10 topics
- Pharmaceutical Industry2▲ 105×2 topics
- Drug Development Costs2▲ 149×1 topic
- Generic Drugs2▲ 149×1 topic
- Economic Evaluation2▲ 25×2 topics
- Cost-effectiveness Analysis1▲ 36×1 topic
- Health Utility Measures1▲ 36×1 topic
- Animal Welfare1▲ 23×4 topics
- Sperm DNA Fragmentation1▲ 58×1 topic
- Spermatogonial Stem Cells1▲ 58×1 topic
- Neurodegeneration1▲ 7.7×3 topics
- Chronic Pain1▲ 10×4 topics
- Classification1▲ 6.0×3 topics
- Metabolism1▲ 3.4×4 topics
- Treatment1▲ 1.70×6 topics
- Deep Learning1◆ 0.97×2 topics
- Literature1▲ 4.2×2 topics
Which research topics does Consorzio per Valutazioni Biologiche e Farmacologiche publish most on?
By volume in 2022–2025: Phytoestrogen effects and research, Pharmaceutical studies and practices, Kidney Stones and Urolithiasis Treatments and Biomarkers in Disease Mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Phytoestrogen effects and research Pathology and Forensic Medicine 0 works
- 2 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 3 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 0 works
- 4 Biomarkers in Disease Mechanisms Immunology 0 works
- 5 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 6 Paleopathology and ancient diseases Archeology 0 works
- 7 Foreign Body Medical Cases Radiology, Nuclear Medicine and Imaging 0 works
- 8 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 9 Alzheimer's disease research and treatments Physiology 0 works
- 10 Immunotoxicology and immune responses Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Consorzio per Valutazioni Biologiche e Farmacologiche's research output changed?
Output in 2018–2022 was 64% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pavia
- University of Pavia
- Policlinico San Matteo Fondazione
- Istituti Clinici Scientifici Maugeri
- Fondazione Salvatore Maugeri
- Istituto di Matematica Applicata e Tecnologie Informatiche
- Istituto Nazionale di Fisica Nucleare, Sezione di Pavia
- Istituto di Genetica Molecolare
- Istituto Universitario di Studi Superiori di Pavia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.